Cancer risk with alemtuzumab following kidney transplantation.

Autor: Puttarajappa, C.1, Yabes, J.2, Bei, L.2, Shah, N.1, Bernardo, J.1, McCauley, J.1, Basu, A.3, Tan, H.3, Shapiro, R.3, Unruh, M.1, Wu, C.1
Zdroj: Clinical Transplantation. May/Jun2013, Vol. 27 Issue 3, pE264-E271. 8p. 1 Diagram, 4 Charts, 3 Graphs.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje